The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...
Tirzepatide is recommended as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity in adults, only if they have: an initial body mass index ...
Bringing you our latest news, features and guidance. Subscribe for information on: our latest guidance implementation advice and case studies consultations, meetings and events the latest news, ...
We have a library of over 200 quality standards and a single menu of indicators. They can be used to help define and measure quality in health, public health and social care. They can be used by ...
Vamorolone (also called Agamree and made by Santhera), is an alternative to currently available corticosteroids used to reduce muscle inflammation and maintain muscle strength and function in people ...
NICE inherited the 7 highly specialised technologies (HST) routing criteria from AGNSS (Advisory Group for National Specialised Services) in 2013. Following that, the NICE Highly Specialised ...
NICE is unable to make a recommendation about the use in the NHS of toripalimab (Loqtorzi) with chemotherapy for untreated advanced oesophageal squamous cell cancer in adults. This is because Shanghai ...
Adults may need support to manage their medicines safely and effectively, and for some people this will be provided as part of a home care service. When medicines support starts, tell the person’s GP ...
Health inequalities modular update to NICE health technology evaluations: the manual (PMG36) Methods / process manual consultation NICE process and methods 31 January 2025 Highly specialised ...
Fever is very common in young children and it can be difficult to distinguish between simple viral illnesses and life-threatening bacterial infections in this group. Our guideline on fever in under 5s ...